ISSN: 1759-5002

Subscribe to this Journal

Journal Home

Journal Guideline

Nature Reviews Cardiology Q1 Unclaimed

Nature Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nature Reviews Cardiology is a journal indexed in SJR in Cardiology and Cardiovascular Medicine with an H index of 183. It has an SJR impact factor of 8,408 and it has a best quartile of Q1. It has an SJR impact factor of 8,408.

Nature Reviews Cardiology focuses its scope in these topics and keywords: surgery, mitral, coronary, access, valve, af, ablation, echocardiographic, drugeluting, distinguished, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cardiology and Cardiovascular Medicine (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

8,408

SJR Impact factor

183

H Index

153

Total Docs (Last Year)

497

Total Docs (3 years)

10482

Total Refs

7493

Total Cites (3 years)

251

Citable Docs (3 years)

14.28

Cites/Doc (2 years)

68.51

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of the American College of Cardiology Q1
Circulation Q1
JAMA Cardiology Q1
European Journal of Heart Failure Q1
Developments in Aquaculture and Fisheries Science Q1

Compare this journals

Aims and Scope

Best articles by citations

Optimizing treatment benefit: individualized therapy or the polypill?

Erratum: Balancing ischaemia and bleeding risks with novel oral anticoagulants

High-dose, prescription omega-3 fatty acids do not prevent recurrent AF

Smart-AV attempts to optimize CRT

Risks and benefits of extended DAPT after stenting

Systems-based approaches to cardiovascular disease

Durable-polymer drug-eluting stents might not lead to very late stent thrombosis

The disconnect between phase II and phase III trials of drugs for heart failure

beta-Blockers - still a trusted ally or time for retirement?

Smartphone-based cardiac rehabilitation - a first RCT

How should the appropriateness of PCI be judged?

Perioperative anticoagulation - are we at 'a bridge too far'?

SHOW MORE ARTICLES

Women living near to a road at increased risk of sudden cardiac death

Management of hypertension in the elderly

Optimum CPR strategies clarified

Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia

Low-dose aspirin failed to improve cardiovascular outcomes

Myocardial salvage with HDL infusion after infarction

Interaction between NOACs and other drugs increases bleeding risk

Detection of ischaemic heart disease in symptomatic women

TTR and HF in black Americans

Clopidogrel-PPI interaction, an ongoing controversy

Statin therapy in men versus women

Strategies to improve cardiac resynchronization therapy